CGEM
NASDAQ · Biotechnology
Cullinan Therapeutics Inc
$10.80
-1.69 (-13.53%)
Analyst Consensus
Strong Buy
19
Analysts
High
Coverage
Price Target
Analyst Price Target
+98.6% upside
Low Target
$16.94
Average Target
$21.45
High Target
$32.37
Current Price
$10.80
Current
$10.80
$10.80
Target
$21.45
$21.45
$16.94
$21.45 avg
$32.37
Scenario Analysis
Bear Case
$16.94
56.9%
Low target
Base Case
$21.45
+98.6%
Avg target
Bull Case
$32.37
+199.7%
High target
Risk/Reward
3.5x
Highly favorable
Price in Context
52-Week High
$23.19
-53.4% from high
52-Week Low
$6.73
+60.4% from low
Target vs 52W High
$21.45
-7.5% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 82% | $257.58 | -11.6% |
| AMGN | Hold | 42 | 43% | $190.87 | -58.5% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +117.3% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -19.9% |
| MRNA | Hold | 31 | 35% | $149.45 | -41.2% |
| REGN | Buy | 37 | 70% | $76.80 | -91.5% |
| NTRA | Strong Buy | 30 | 90% | $142.91 | -54.0% |
| RVMD | Strong Buy | 29 | 93% | $114.11 | -40.7% |